ID   1A245.6
AC   CVCL_LC05
DR   Wikidata; Q54582646
RX   Patent=US7175846;
RX   Patent=US7431923;
RX   Patent=US7488475;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4889.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 5
//
RX   Patent=US7431923;
RA   Young, David S.F.
RA   Hahn, Susan E.
RA   Findlay, Helen P.
RA   da Cruz, Luis A.G.
RT   "Cytotoxicity mediation of cells evidencing surface expression of
RT   CD63.";
RL   Patent number US7431923, 07-Oct-2008.
//
RX   Patent=US7175846;
RA   Young, David S.F.
RA   Hahn, Susan E.
RA   Findlay, Helen P.
RT   "Cancerous disease modifying antibodies.";
RL   Patent number US7175846, 13-Feb-2007.
//
RX   Patent=US7488475;
RA   Young, David S.F.
RA   Hahn, Susan E.
RA   Findlay, Helen P.
RT   "Antibody therapy of tumors.";
RL   Patent number US7488475, 10-Feb-2009.
//